|
---|
As Of | Filer | Filing¹ | For·On·As | Docs:Size | Issuer | | Filing Agent | | | | | | | | | |
---|
|
---|
2/14/05 Polaris Venture Partners III LP SC 13G 1:30K Momenta Pharmaceuticals Inc. Bowne of Boston/FA
Alan G. Spoon³
Jonathan A. Flint³
Polaris Venture Management Co. III, L.L.C.³
Polaris Venture Partners Entrepeneurs’ Fund III, L.P.³
Polaris Venture Partners Founders’ Fund III, L.P.³
Stephen D. Arnold³
Terrance G. McGuire³
2/14/05 Polaris Venture Partners III LP SC 13G/A 1:30K Alnylam Pharmaceuticals, Inc. Bowne of Boston/FA
Alan G. Spoon³
Jonathan A. Flint³
Polaris Venture Management Co. III, L.L.C.³
Polaris Venture Partners Entrepeneurs’ Fund III, L.P.³
Polaris Venture Partners Founders’ Fund III, L.P.³
Stephen D. Arnold³
Terrance G. McGuire³
____________ | ¹ | Filing/Form Type: | | SC 13G | Statement of Acquisition of Beneficial Ownership by a “Passive” Investor — Schedule 13G. | | /A | Amendment to, or Amended version of, a previous Filing of this Type. | ³ | Group Member: A Registrant or non-Registrant party to this Filing made by a Group. |
|